サンプル依頼リスト カート
  • English
  • Korean
表紙：API（医薬品原薬）中間体の世界市場規模調査＆予測、タイプ別、用途別、エンドユーザー別、地域別分析、2023-2030年
市場調査レポート
商品コード
1389169

API（医薬品原薬）中間体の世界市場規模調査＆予測、タイプ別、用途別、エンドユーザー別、地域別分析、2023-2030年

Global API Intermediate Market Size Study & Forecast, by Type, by Application, by End User, and by Regional Analysis, 2023-2030
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
API（医薬品原薬）中間体の世界市場規模調査＆予測、タイプ別、用途別、エンドユーザー別、地域別分析、2023-2030年
出版日: 2023年10月30日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のAPI（医薬品原薬）中間体市場は2022年に約1,394億米ドルと評価され、予測期間2023-2030年には7.4%以上の健全な成長率で成長すると予測されています。

医薬品有効成分（API）中間体は、一般に医薬品中間体と呼ばれ、APIの合成または製造過程で形成される化学化合物または物質です。医薬品の製剤化に利用される最終的な医薬品有効成分は、これらの中間体から製造され、これらの中間体は必須の構成要素または前駆体分子です。API（医薬品原薬）中間体は新規医薬品の開発に使用されます。原薬の製造には、API（医薬品原薬）中間体として知られる化合物を構成要素または前駆体として使用します。品質管理工程では、API（医薬品原薬）中間体を参照標準として使用します。ジェネリック医薬品の需要の急増、受託製造やアウトソーシングの動向の高まり、心血管疾患、糖尿病、がん、呼吸器疾患などの慢性疾患の有病率の増加、老年人口の増加と相まって、世界のAPI（医薬品原薬）中間体市場の主な促進要因となっています。

さらに、バイオ医薬品産業の盛んな成長は、推定期間中の市場需要の触媒として作用しています。バイオ医薬品は、タンパク質、遺伝子、細胞などの生物学的材料を使用して製造される医薬品の一種です。タンパク質、DNA、細胞などの生物学的成分は、特定のクラスの薬であるバイオ医薬品を製造するために使用されます。これらの医薬品は非常に人気があり、従来の低分子医薬品よりも効率的です。バイオ医薬品分野の拡大は、バイオ医薬品の製造に必要なAPI（医薬品原薬）中間体の需要を押し上げています。Statistaによると、2022年のバイオ医薬品セクターの売上高は世界全体で4,031億米ドルと推定され、今後も成長が見込まれ、2030年には9,745億米ドルを突破すると見られています。したがって、これらの要因は、推定期間2023-2030におけるAPI（医薬品原薬）中間体市場の成長を強化しています。さらに、個別化医療への注目の高まりや研究開発への投資の増加は、予測期間中に様々な有利な機会をもたらします。しかし、厳しい政府規制の賦課と熟練労働者と専門知識の限られた利用可能性は、2023年から2030年の予測期間を通じて市場の成長に課題しています。

API（医薬品原薬）中間体の世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、地域の製薬会社が新薬を発見し、既存の製剤を改善するための研究開発活動に多額の投資を行っているため、2022年の市場を独占しました。また、連続製造やプロセス分析技術（PAT）の利用など、医薬品製造技術の進歩により、原薬製造の効率と品質が向上しています。一方、アジア太平洋地域は予測期間中に最も高いCAGRで成長すると予想されています。慢性疾患の増加、人口の急増、手頃な価格の医療に対する需要の高まり、インドや中国などの新興経済国における製薬産業の拡大とともに、いくつかのブランド医薬品の特許切れなどの要因が、この地域全体の市場需要を大きく押し上げています。

本調査の目的は、近年における様々なセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 世界のAPI（医薬品原薬）中間体市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 業界の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 API（医薬品原薬）中間体の世界市場力学

  • API（医薬品原薬）中間体市場の影響分析（2020-2030年）
    • 市場促進要因
      • ジェネリック医薬品需要の急増
      • バイオ医薬品産業の成長
    • 市場の課題
      • 厳しい政府規制の賦課
      • 熟練労働者や専門知識の不足
    • 市場機会
      • 個別化医療への注目の高まり
      • 研究開発投資の増加

第4章 世界のAPI（医薬品原薬）中間体市場産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 API（医薬品原薬）中間体の世界市場：タイプ別

  • 市場スナップショット
  • API（医薬品原薬）中間体の世界市場：タイプ別実績-ポテンシャル分析
  • API（医薬品原薬）中間体の世界市場、タイプ別推定・予測：2020-2030年
  • API（医薬品原薬）中間体の世界市場、サブセグメント別分析
    • API（医薬品原薬）中間体
    • 化学中間体

第6章 API（医薬品原薬）中間体の世界市場：用途別

  • 市場スナップショット
  • API（医薬品原薬）中間体の世界市場：用途別実績-ポテンシャル分析
  • API（医薬品原薬）中間体の世界市場、用途別推定・予測2020-2030年
  • API（医薬品原薬）中間体の世界市場、サブセグメント別分析
    • 鎮痛薬
    • 抗感染症薬
    • 抗糖尿病薬
    • 心血管治療薬
    • 抗がん剤
    • その他

第7章 API（医薬品原薬）中間体の世界市場：エンドユーザー別

  • 市場スナップショット
  • API（医薬品原薬）中間体の世界市場：エンドユーザー別実績 - ポテンシャル分析
  • API（医薬品原薬）中間体の世界市場：エンドユーザー別推定・予測2020年～2030年
  • API（医薬品原薬）中間体の世界市場、サブセグメント別分析
    • バイオテクノロジーおよび製薬企業
    • CMO
    • その他

第8章 API（医薬品原薬）中間体の世界市場：地域別分析

  • 主要国
  • 主な新興国
  • API（医薬品原薬）中間体の世界市場、地域別市場スナップショット
  • 北米
    • 米国
      • タイプの推定・予測、2020-2030年
      • 用途の推定・予測、2020-2030年
      • エンドユーザーの推定・予測、2020-2030年
    • カナダ
  • 欧州API（医薬品原薬）中間体市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋API（医薬品原薬）中間体市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカAPI（医薬品原薬）中間体市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他中東とアフリカ

第9章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Espee Group
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 最近の動向
    • Hikal Ltd
    • Anyang General Chemical Co., Ltd.
    • Evonik Industries AG
    • Sandoo Pharmaceuticals and Chemicals Co., Ltd.
    • Cambrex Corporation
    • Sanofi
    • Cation Pharma
    • Pfizer Inc.
    • BASF SE

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1. Global API Intermediate Market, report scope
  • TABLE 2. Global API Intermediate Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global API Intermediate Market estimates & forecasts by Type 2020-2030 (USD Billion)
  • TABLE 4. Global API Intermediate Market estimates & forecasts by Application 2020-2030 (USD Billion)
  • TABLE 5. Global API Intermediate Market estimates & forecasts by End User 2020-2030 (USD Billion)
  • TABLE 6. Global API Intermediate Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global API Intermediate Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global API Intermediate Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global API Intermediate Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global API Intermediate Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global API Intermediate Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global API Intermediate Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global API Intermediate Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global API Intermediate Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global API Intermediate Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. API Intermediate Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. U.S. API Intermediate Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. U.S. API Intermediate Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19. Canada API Intermediate Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 20. Canada API Intermediate Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. Canada API Intermediate Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22. UK API Intermediate Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 23. UK API Intermediate Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. UK API Intermediate Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25. Germany API Intermediate Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 26. Germany API Intermediate Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. Germany API Intermediate Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28. France API Intermediate Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 29. France API Intermediate Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. France API Intermediate Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31. Italy API Intermediate Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 32. Italy API Intermediate Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Italy API Intermediate Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34. Spain API Intermediate Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 35. Spain API Intermediate Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. Spain API Intermediate Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37. RoE API Intermediate Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 38. RoE API Intermediate Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. RoE API Intermediate Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40. China API Intermediate Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 41. China API Intermediate Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. China API Intermediate Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43. India API Intermediate Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 44. India API Intermediate Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. India API Intermediate Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46. Japan API Intermediate Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 47. Japan API Intermediate Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. Japan API Intermediate Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49. South Korea API Intermediate Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 50. South Korea API Intermediate Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. South Korea API Intermediate Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52. Australia API Intermediate Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 53. Australia API Intermediate Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. Australia API Intermediate Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC API Intermediate Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC API Intermediate Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC API Intermediate Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58. Brazil API Intermediate Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 59. Brazil API Intermediate Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Brazil API Intermediate Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61. Mexico API Intermediate Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 62. Mexico API Intermediate Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. Mexico API Intermediate Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64. RoLA API Intermediate Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 65. RoLA API Intermediate Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. RoLA API Intermediate Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67. Saudi Arabia API Intermediate Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 68. South Africa API Intermediate Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. RoMEA API Intermediate Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global API Intermediate Market
  • TABLE 71. List of primary sources, used in the study of global API Intermediate Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global API Intermediate Market, research methodology
  • FIG 2. Global API Intermediate Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global API Intermediate Market, key trends 2022
  • FIG 5. Global API Intermediate Market, growth prospects 2023-2030
  • FIG 6. Global API Intermediate Market, porters 5 force model
  • FIG 7. Global API Intermediate Market, pest analysis
  • FIG 8. Global API Intermediate Market, value chain analysis
  • FIG 9. Global API Intermediate Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global API Intermediate Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global API Intermediate Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global API Intermediate Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global API Intermediate Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global API Intermediate Market, regional snapshot 2020 & 2030
  • FIG 15. North America API Intermediate Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe API Intermediate Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific API Intermediate Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America API Intermediate Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa API Intermediate Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global API Intermediate Market is valued at approximately USD 139.4 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 7.4% over the forecast period 2023-2030. Active Pharmaceutical Ingredient (API) intermediates commonly referred to as drug intermediates, are chemical compounds or substances formed during the synthesis or manufacturing process of an API. The final active pharmaceutical component utilized in the formulation of medicines is produced from these intermediates, which are the essential building blocks or precursor molecules. API intermediates are used in developing novel pharmaceutical substances. The production of APIs uses compounds known as API intermediates as building blocks or precursors. The quality control processes use API intermediates as reference standards. The surge in demand for generic drugs, the rising trend of contract manufacturing and outsourcing, increase in the prevalence of chronic diseases such as cardiovascular disorders, diabetes, cancer, and respiratory ailments, coupled with the escalating geriatric populations are the key driving factors for the global API Intermediate Market.

In addition, the flourishing growth of the biopharmaceutical industry is acting as a catalyzing factor for the market demand during the estimated period. Biopharmaceuticals are a type of drug that is produced using biological materials, such as proteins, genes, and cells. Biological components including proteins, DNA, and cells are used to make biopharmaceuticals, a specific class of medication. These drugs are extremely popular and are more efficient than conventional small-molecule medicines. The expansion of the biopharmaceutical sector is boosting demand for API intermediates as they are necessary for the creation of biopharmaceuticals. As per Statista, in 2022, it was estimated that the biopharmaceuticals sector account for USD 403.1 billion globally, is expected to continue to grow, and is likely to surpass USD 974.5 billion by 2030. Hence, these factors are bolstering the growth of the API Intermediate Market in the estimated period 2023-2030. Moreover, the growing focus on personalized medicine, as well as increasing investments in research and development present various lucrative opportunities over the forecast years. However, the imposition of stringent government regulations and the limited availability of skilled labor and expertise are challenging the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global API Intermediate Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the regional pharmaceutical companies heavily investing in research and development activities to discover new drugs and improve existing drug formulations. Also, advances in pharmaceutical manufacturing techniques, such as continuous manufacturing and the use of process analytical technology (PAT), have improved the efficiency and quality of API production. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecast years. Factors such as the rise in chronic diseases, spurring population, growing demand for affordable healthcare, and the expiration of patents for several branded drugs, along with the expansion of the pharmaceutical industry in emerging economies such as India and China are significantly propelling the market demand across the region.

Major market players included in this report are:

  • Espee Group
  • Hikal Ltd
  • Anyang General Chemical Co., Ltd.
  • Evonik Industries AG
  • Sandoo Pharmaceuticals and Chemicals Co., Ltd.
  • Cambrex Corporation
  • Sanofi
  • Cation Pharma
  • Pfizer Inc.
  • BASF SE

Recent Developments in the Market:

  • In March 2022, Sumitomo Chemical Co., Ltd., a Japanese chemical company announced that the company builds a new manufacturing facility for active pharmaceutical ingredients (APIs) and intermediates for small molecule drugs at its Oita Works (Oita City, Oita Prefecture, Japan) to increase its ability to meet the rising demand for small molecule drugs.

Global API Intermediate Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Type, Application, End User, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

  • Bulk Drug Intermediates
  • Chemical Intermediates

By Application:

  • Analgesics
  • Anti-Infective Drugs
  • Antidiabetic Drugs
  • Cardiovascular Drugs
  • Anticancer Drugs
  • Others

By End User:

  • Biotech and Pharmaceutical Companies
  • CMO
  • Others

By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • ROE
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. API Intermediate Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. API Intermediate Market, by Type, 2020-2030 (USD Billion)
    • 1.2.3. API Intermediate Market, by Application, 2020-2030 (USD Billion)
    • 1.2.4. API Intermediate Market, by End User, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global API Intermediate Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global API Intermediate Market Dynamics

  • 3.1. API Intermediate Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Surge in demand for generic drugs
      • 3.1.1.2. Flourishing growth of the biopharmaceutical industry
    • 3.1.2. Market Challenges
      • 3.1.2.1. Imposition of stringent government regulations
      • 3.1.2.2. Limited availability of skilled labor and expertise
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Growing focus on personalized medicine
      • 3.1.3.2. Increasing investments in research and development

Chapter 4. Global API Intermediate Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global API Intermediate Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Global API Intermediate Market by Type, Performance - Potential Analysis
  • 5.3. Global API Intermediate Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
  • 5.4. API Intermediate Market, Sub Segment Analysis
    • 5.4.1. Bulk Drug Intermediates
    • 5.4.2. Chemical Intermediates

Chapter 6. Global API Intermediate Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global API Intermediate Market by Application, Performance - Potential Analysis
  • 6.3. Global API Intermediate Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
  • 6.4. API Intermediate Market, Sub Segment Analysis
    • 6.4.1. Analgesics
    • 6.4.2. Anti-Infective Drugs
    • 6.4.3. Antidiabetic Drugs
    • 6.4.4. Cardiovascular Drugs
    • 6.4.5. Anticancer Drugs
    • 6.4.6. Others

Chapter 7. Global API Intermediate Market, by End User

  • 7.1. Market Snapshot
  • 7.2. Global API Intermediate Market by End User, Performance - Potential Analysis
  • 7.3. Global API Intermediate Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
  • 7.4. API Intermediate Market, Sub Segment Analysis
    • 7.4.1. Biotech and Pharmaceutical Companies
    • 7.4.2. CMO
    • 7.4.3. Others

Chapter 8. Global API Intermediate Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. API Intermediate Market, Regional Market Snapshot
  • 8.4. North America API Intermediate Market
    • 8.4.1. U.S. API Intermediate Market
      • 8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. End User breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada API Intermediate Market
  • 8.5. Europe API Intermediate Market Snapshot
    • 8.5.1. U.K. API Intermediate Market
    • 8.5.2. Germany API Intermediate Market
    • 8.5.3. France API Intermediate Market
    • 8.5.4. Spain API Intermediate Market
    • 8.5.5. Italy API Intermediate Market
    • 8.5.6. Rest of Europe API Intermediate Market
  • 8.6. Asia-Pacific API Intermediate Market Snapshot
    • 8.6.1. China API Intermediate Market
    • 8.6.2. India API Intermediate Market
    • 8.6.3. Japan API Intermediate Market
    • 8.6.4. Australia API Intermediate Market
    • 8.6.5. South Korea API Intermediate Market
    • 8.6.6. Rest of Asia Pacific API Intermediate Market
  • 8.7. Latin America API Intermediate Market Snapshot
    • 8.7.1. Brazil API Intermediate Market
    • 8.7.2. Mexico API Intermediate Market
  • 8.8. Middle East & Africa API Intermediate Market
    • 8.8.1. Saudi Arabia API Intermediate Market
    • 8.8.2. South Africa API Intermediate Market
    • 8.8.3. Rest of Middle East & Africa API Intermediate Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Espee Group
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. Hikal Ltd
    • 9.3.3. Anyang General Chemical Co., Ltd.
    • 9.3.4. Evonik Industries AG
    • 9.3.5. Sandoo Pharmaceuticals and Chemicals Co., Ltd.
    • 9.3.6. Cambrex Corporation
    • 9.3.7. Sanofi
    • 9.3.8. Cation Pharma
    • 9.3.9. Pfizer Inc.
    • 9.3.10. BASF SE

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption